Learning Objectives:

1.  To understand the latest clinical data in the adjuvant/front-line mRCC setting 

2.  To appreciate emerging biomarkers to inform clinical decision-making

3.  To realize ongoing trials in the advanced RCC setting

Session date: 
05/02/2022 - 12:00pm to 1:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Brian Rini, MD FASCO